The Future of Gene Patents and the Implications for Medicine

173 JAMA Internal Medicine 1569, Sept. 2013

2 Pages Posted: 15 Sep 2013 Last revised: 25 Sep 2013

See all articles by Jacob S. Sherkow

Jacob S. Sherkow

University of Illinois College of Law; University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology; Center for Advanced Studies in Biomedical Innovation Law

Henry T. Greely

Stanford Law School

Date Written: September 23, 2013

Abstract

The Supreme Court decision in Myriad Genetics struck down the patenting of human genomic DNA. What will this mean for genetic testing and medicine, more broadly?

Keywords: gene, genetic, patent, intellectual property, myriad, amp, medicine, BRCA, cancer

JEL Classification: K00, K11, O3, O34

Suggested Citation

Sherkow, Jacob S. and Greely, Henry (Hank) T., The Future of Gene Patents and the Implications for Medicine (September 23, 2013). 173 JAMA Internal Medicine 1569, Sept. 2013, Available at SSRN: https://ssrn.com/abstract=2325679

Jacob S. Sherkow (Contact Author)

University of Illinois College of Law ( email )

504 E. Pennsylvania Avenue
Champaign, IL 61820
United States

University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology ( email )

Urbana, IL
United States

Center for Advanced Studies in Biomedical Innovation Law ( email )

Studiestraede 6
Studiestrade 6
Copenhagen, DK-1455
Denmark

HOME PAGE: http://jura.ku.dk/cebil/staff/

Henry (Hank) T. Greely

Stanford Law School ( email )

559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-723-2517 (Phone)
650-725-0253 (Fax)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
218
Abstract Views
1,212
rank
174,500
PlumX Metrics